| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | P2RY4 |
| Uniprot No | P51582 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-365 aa |
| 活性数据 | MASTESSLLRSLGLSPGPGSSEVELDCWFDEDFKFILLPVSYAVVFVLGLGLNAPTLWLF IFRLRPWDATATYMFHLALSDTLYVLSLPTLIYYYAAHNHWPFGTEICKFVRFLFYWNLY CSVLFLTCISVHRYLGICHPLRALRWGRPRLAGLLCLAVWLVVAGCLVPNLFFVTTSNKG TTVLCHDTTRPEEFDHYVHFSSAVMGLLFGVPCLVTLVCYGLMARRLYQPLPGSAQSSSR LRSLRTIAVVLTVFAVCFVPFHITRTIYYLARLLEADCRVLNIVNVVYKVTRPLASANSC LDPVLYLLTGDKYRRQLRQLCGGGKPQPRTAASSLALVSLPEDSSCRWAATPQDSSCSTP RADRL |
| 分子量 | 40.9 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | 0 |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是3篇关于人P2Y4受体（P2RY4）的参考文献摘要概览：
---
1. **文献名称**: *Cloning and functional characterization of the human P2Y4 receptor*
**作者**: Kennedy C. et al. (2000)
**摘要**: 本研究首次克隆并表达了人源P2Y4受体，揭示了其在HEK293细胞中通过UTP激活后介导的Gq信号通路，诱导细胞内钙离子动员，并证实其与肠道上皮氯离子分泌的相关性。
---
2. **文献名称**: *Recombinant expression and pharmacological characterization of the human P2Y4 receptor in Xenopus oocytes*
**作者**: Bogdanov Y. et al. (1998)
**摘要**: 通过在非洲爪蟾卵母细胞中重组表达人P2Y4受体，发现其对ATP和UTP的响应性差异，提出P2Y4可能通过双重激动剂机制调控细胞膜离子通道活性。
---
3. **文献名称**: *Structural insights into ligand recognition and activation of the human P2Y4 receptor*
**作者**: Zhang D. et al. (2022)
**摘要**: 结合冷冻电镜技术与分子动力学模拟，解析了人P2Y4受体与UTP结合的复合物结构，揭示了其配体结合口袋特征及激活后的构象变化机制，为靶向药物设计提供依据。
---
*注：P2Y4受体研究相对较少，以上文献标题与内容均为基于领域知识的模拟概括，实际发表年份及细节需以真实数据库检索结果为准。建议通过PubMed或Web of Science以“P2Y4 receptor recombinant”等关键词进一步筛选文献。*
**Background of Recombinant Human P2RY4 (P2Y4) Protein**
The P2RY4 protein, also known as P2Y₄, is a member of the P2Y receptor family, a class of G protein-coupled receptors (GPCRs) activated by extracellular nucleotides. In humans, P2Y4 is primarily activated by uridine triphosphate (UTP) and, to a lesser extent, by ATP, depending on species-specific variations. It plays a critical role in purinergic signaling, influencing physiological processes such as ion transport, epithelial secretion, and cellular proliferation.
Structurally, P2Y4 consists of seven transmembrane domains typical of GPCRs, with extracellular loops involved in ligand binding. It couples to Gq/11 proteins, triggering intracellular calcium mobilization and downstream signaling pathways. Tissue-specific expression is observed in the gastrointestinal tract, salivary glands, and respiratory epithelium, where it regulates fluid and electrolyte homeostasis.
Recombinant human P2Y4 protein is produced via heterologous expression systems (e.g., mammalian cells), enabling studies on receptor pharmacology, ligand interactions, and structure-function relationships. Its recombinant form is vital for drug discovery, particularly in targeting disorders like inflammatory bowel disease, cystic fibrosis, or secretory diarrhea, where aberrant purinergic signaling is implicated. Additionally, it aids in deciphering the receptor's role in pathological conditions, such as cancer metastasis or chronic inflammation.
Research on P2Y4 highlights its therapeutic potential and underscores the need for selective agonists/antagonists to modulate its activity in disease contexts.
×
